Neocement® Inject P for dental bone augmentation and regeneration.
Official title: Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area
Run by Bioceramed · NCT07179510 · Data updated 2026-11-12
This study will try Neocement® Inject P, an injectable calcium‑phosphate bone substitute, in adults having reconstructive dental or maxillofacial surgery to see if it is safe and helps bone heal.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | Bioceramed Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 1 site (Lisbon) |
| Status | Recruiting |
| Started | October 6, 2025 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07179510 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) scheduled for reconstructive dental or maxillofacial surgery with non‑load‑bearing bone defects and no active infection, metabolic contraindication, or known material hypersensitivity.
✕Probably not a fit
Patients with active local or systemic infection, metabolic bone disease, unstable or load‑bearing implantation sites, or known hypersensitivity to the implant materials are unlikely to benefit from this device.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational study collecting real‑world clinical data on the performance and safety of Neocement® Inject P when used according to its intended indications in dental and maxillofacial procedures. The device is an injectable, single‑use calcium phosphate and chitosan bone substitute delivered as a two‑part system intended to fill non‑load‑bearing bony voids and support bone regeneration. Adult patients undergoing reconstructive dental surgery who provide informed consent will have device handling, clinical outcomes, and adverse events recorded under a predefined observational protocol. The collected data will serve as clinical evidence to inform the device's clinical evaluation.
Why it matters
Potential benefit: If successful, Neocement® Inject P could improve bone quality and accelerate bone healing after dental reconstructive procedures.
How similar studies have gone: Injectable calcium‑phosphate bone substitutes similar to Neocement® Inject P have clinical precedent with documented bone healing and acceptable safety profiles in comparable indications.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult males or females (age \> 18 years old); * Patients who are able to sign an informed consent form (for data collection); * Patients undergoing reconstructive dental surgery and indicated for the use of Neocement® Inject P; Exclusion Criteria: * Patients who are unable to understand consent and the objectives of the study; * Signs of local or systemic acute/ active or chronic infections; * Metabolic affections; * Severe degenerative diseases, conditions in which general bone grafting is not advisable; * Implementation sites that allow product migration; * Conditions which require structural support in the skeletal system; * Conditions where the implantation site is unstable and not rigidly fixated; * Sensibility to the implantable materials; * Known hypersensitivity to the implant material.
Where it's running
-
Egas Moniz School of Health and Science
Lisbon, Portugal Recruiting
Study contacts
- Principal investigator: João Botelho — Egas Moniz School of Health and Science Caparica, Lisboa, Portugal
- Study coordinator: Alexandre Barros
- Email: info@bioceramed.com
- Phone: 253 573 460
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced hydrogel xenograft for open maxillary sinus augmentation
This study tests a hydrogel-enhanced xenograft material to lift the sinus floor during open augmentation and sees if it improves bone formation and tissue response compared with doing the augmentation without graft material.
-
Neobone® safety and performance in dental bone grafting
This project will collect real-world data to see if Neobone® is safe and helps bone heal in adults having reconstructive dental procedures.
-
Bone grafting at implant removal to help success of putting a new implant in the same spot
This study tests whether doing bone grafting at the same time as removing a failed dental implant helps people who plan to get a new implant in the same location.
-
Rebuilding upper jaw ridge using retromolar bone blocks with or without a collagen membrane
This will test whether putting a collagen membrane over an onlay bone block and particulate bone in the upper jaw helps people who need ridge rebuilding get more bone.
-
One-stage ridge splitting in the back lower jaw using two techniques
This compares two surgical methods—piezo surgery versus conventional bone-disc cuts—to widen the narrow back lower jaw so dental implants can be placed in adults with limited ridge width.
-
One-stage ridge splitting in the upper jaw using piezo surgery or a bone-disc technique
We will try two ridge-splitting techniques—piezo surgery and bone discs—to widen narrow upper-jaw bone in adults needing a single-tooth implant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.